Skip to main content
Journal cover image

Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.

Publication ,  Journal Article
Santisteban, I; Arredondo-Vega, FX; Kelly, S; Loubser, M; Meydan, N; Roifman, C; Howell, PL; Bowen, T; Weinberg, KI; Schroeder, ML
Published in: Hum Mol Genet
November 1995

We report three novel adenosine deaminase (ADA) mutations with interesting implications. A Somali child with severe combined immunodeficiency disease (SCID) had reduced ADA mRNA in T cells and was homozygous for the nonsense mutation Q3X. Unexpectedly, her healthy father was a compound ADA heterozygote whose second allele carried a 'partial' mutation, R142Q, due to a G-->A transition of a CpG dinucleotide. A C-->T transition of the same CpG produced a nonsense mutation, R142X, in two homozygous Canadian Mennonite infants with SCID. The severe and healthy phenotypes associated with R142X and R142Q, the high frequency of 'partial' ADA mutations arising from CpGs in healthy individuals of African descent and the presence of CAA (glutamine) at codon 142 in murine ADA, suggest selection for replacement of this CpG hotspot by CpA during ADA evolution. R142X, located within a purine-rich segment at nt 62/116 of exon 5, caused skipping of the exon, possibly by disrupting a splicing enhancer. Absence of exon 5 in T cell ADA mRNA and low ADA activity in T cells and erythrocytes obtained at age 18-22 months from one of the Mennonite children, indicate limited expression of a normal ADA cDNA from retrovirally transduced CD34+ umbilical cord leukocytes infused shortly after birth in an attempt at stem cell gene therapy.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Hum Mol Genet

DOI

ISSN

0964-6906

Publication Date

November 1995

Volume

4

Issue

11

Start / End Page

2081 / 2087

Location

England

Related Subject Headings

  • Severe Combined Immunodeficiency
  • RNA Splicing
  • Phenotype
  • Pedigree
  • Mutation
  • Molecular Sequence Data
  • Male
  • Infant
  • Humans
  • Genetics & Heredity
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Santisteban, I., Arredondo-Vega, F. X., Kelly, S., Loubser, M., Meydan, N., Roifman, C., … Schroeder, M. L. (1995). Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet, 4(11), 2081–2087. https://doi.org/10.1093/hmg/4.11.2081
Santisteban, I., F. X. Arredondo-Vega, S. Kelly, M. Loubser, N. Meydan, C. Roifman, P. L. Howell, T. Bowen, K. I. Weinberg, and M. L. Schroeder. “Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA.Hum Mol Genet 4, no. 11 (November 1995): 2081–87. https://doi.org/10.1093/hmg/4.11.2081.
Santisteban I, Arredondo-Vega FX, Kelly S, Loubser M, Meydan N, Roifman C, Howell PL, Bowen T, Weinberg KI, Schroeder ML. Three new adenosine deaminase mutations that define a splicing enhancer and cause severe and partial phenotypes: implications for evolution of a CpG hotspot and expression of a transduced ADA cDNA. Hum Mol Genet. 1995 Nov;4(11):2081–2087.
Journal cover image

Published In

Hum Mol Genet

DOI

ISSN

0964-6906

Publication Date

November 1995

Volume

4

Issue

11

Start / End Page

2081 / 2087

Location

England

Related Subject Headings

  • Severe Combined Immunodeficiency
  • RNA Splicing
  • Phenotype
  • Pedigree
  • Mutation
  • Molecular Sequence Data
  • Male
  • Infant
  • Humans
  • Genetics & Heredity